Warfarin Pharmacogenetics: Controversy Regarding Genotyping
{"Image DocumentName": "Warfarin Pharmacogenetics: Controversy Regarding Genotyping", "Image ImageDescription": "Change in warfarin. label (2007) and dosing tables (2010) We genotyped 201 warfarin-treated patients for five common polymorphisms in and around VKORC1, and all covaried significantly with warfarin dose. VKORC1 has a larger impact on warfarin dose than CYP2C9, which affects dosing through polymorphic metabolism of warfarin.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}